"ʻOliʻoli mākou i ka hoʻolauna ʻana i kēia lāʻau lapaʻau koʻikoʻi i ka poʻe Kanada e noho nei me kēia maʻi maʻamau, pale a nānā ʻole ʻia. He mea koʻikoʻi kēia hoʻolaha no Sun Pharma, ʻoiai mākou e hoʻonui i kā mākou dermatology portfolio i Kanada, "wahi a Abhay Gandhi, Luna Nui o ʻAmelika ʻAmelika, Sun Pharma. "Me ʻelima mau makahiki o ka mālama maikaʻi ʻana i ka psoriasis plaque haʻahaʻa a koʻikoʻi, hōʻike ʻo ILUMYA i kā mākou kūpaʻa i ka hāʻawi ʻana i nā lāʻau lapaʻau hou e kākoʻo i ka nohona maʻi a me ke koho kauka."

ʻO Plaque psoriasis kahi maʻi autoimmune mau loa e ʻike ʻia ma ka ʻili e like me ka ʻulaʻula, nā wahi i hoʻokiʻekiʻe ʻia o ka ʻili i uhi ʻia me nā unahi keʻokeʻo keʻokeʻo hiki ke pohā a kahe ke koko. Hoʻopilikia ia ma kahi o hoʻokahi miliona mau Kanaka. Hoʻopilikia ka psoriasis plaque ma kahi o 35% o nā maʻi. ʻO kahi paʻakikī koʻikoʻi, ʻo ka nui o nā lāʻau lapaʻau e hoʻōki i ka hana ʻoi aku ka manawa a hoʻi hou nā hōʻailona. ʻO ka lōʻihi o ka mālama ʻana i ka wā lōʻihi he mea pono ʻole ia no nā maʻi he nui.

"Hiki i ka psoriasis plaque haʻahaʻa a koʻikoʻi ke paʻakikī i ka hōʻoluʻolu ʻana i kou ʻili ponoʻī a ʻo ka ʻimi ʻana i kahi lāʻau lapaʻau e like me ka maʻi ponoʻī," wahi a Kauka Melinda Gooderham, he Dermatologist a me ka Luna Hoʻokele Lapaʻau i hōʻoia ʻia e ka papa. ma ka SKiN Center for Dermatology ma Peterborough, Ontario. "Pono kā mākou poʻe maʻi i nā koho no ka mālama maikaʻi, lōʻihi a hoʻomau i Kanada a e kōkua ʻo ILUMYA e hoʻokō i kēlā pono."

I loko o kahi puke pai i hoʻopaʻa ʻia e nā hoa e pili ana i nā hōʻike ʻana o nā hoʻāʻo ʻelua ʻo reSURFACE 1 a me reSURFACE 2, hōʻike ka ʻikepili i ka hapa nui o nā maʻi ma ILUMYA i mālama i ka pane a me ka hōʻoia palekana ma o 5 mau makahiki o ka mālama ʻana.

I nā poʻe maʻi i mālama ʻia me ILUMYA 100 mg, kokoke ʻeiwa o 10 i mālama i kā lākou pane ma o ka makahiki 5. Ua ʻae maikaʻi ʻia ʻo ILUMYA 100 mg i ka wā o nā hoʻokolohua Phase 3. ʻO nā hopena ʻino ʻekolu i loaʻa pinepine ʻia ma mua o kahi placebo a me ≥1% i nā hoʻokolohua lapaʻau, ʻo ia nā maʻi o ka hanu kiʻekiʻe (15.1% vs. 12.3%), nā hopena o ka wahi injection (3.9% vs. 2.6%) a me ke poʻo (3.2% vs. 2.9%). ).

Ma Kanada, ua hōʻike ʻia kekahi mau maʻi i komo i loko o ke aʻo ʻana i ka ʻili maʻemaʻe i ʻewalu mau makahiki ma hope.

"He mau maʻi koʻu i mālama ʻia me ka ILUMYA no nā makahiki ʻewalu i hala iho nei, a ua ʻike au i ko lākou ʻili e hoʻomaikaʻi i nā pae kiʻekiʻe o ka ʻae, a noho mālie no ka wā lōʻihi. ʻO ka hopena, ua hoʻomaikaʻi hou ko lākou ola, "wahi a Kauka Gooderham.

"I koʻu ola a pau, ua hakakā wau me ka psoriasis plaque haʻahaʻa a koʻikoʻi, a hoʻololi mau wau i waena o nā ʻaila a me nā ʻaila i hana ʻole a hoʻohui wale i koʻu kaumaha. A hiki i koʻu aʻo ʻana e pili ana i ka ILUMYA, manaʻo wau ua pau nā koho lapaʻau," wahi a Ainsley Leween, ka maʻi psoriasis. "Mai koʻu hoʻomaka ʻana e hoʻohana i ka ILUMYA ʻewalu mau makahiki i hala aku nei, ua mālama ʻia koʻu psoriasis."

Ua ʻōlelo maikaʻi ʻo Canadian Agency for Drugs and Technologies in Health (CADTH), ma o ka Common Drug Review, i nā panalāʻau e pili ana i ka huahana ILUMYA e uku hou ʻia no nā poʻe maʻi me ka psoriasis plaque haʻahaʻa a paʻakikī, ke kuhikuhi ʻia e ka dermatologist.

He aha e lawe ʻia mai kēia ʻatikala:

I loko o kahi puke pai i hoʻopaʻa ʻia e nā hoa e pili ana i nā hōʻike ʻana o nā hoʻāʻo ʻelua ʻo reSURFACE 1 a me reSURFACE 2, hōʻike ka ʻikepili i ka hapa nui o nā maʻi ma ILUMYA i mālama i ka pane a me ka hōʻoia palekana ma o 5 mau makahiki o ka mālama ʻana.
Ua ʻōlelo maikaʻi ʻo Canadian Agency for Drugs and Technologies in Health (CADTH), ma o ka Common Drug Review, i nā panalāʻau e pili ana i ka huahana ILUMYA e uku hou ʻia no nā poʻe maʻi me ka psoriasis plaque haʻahaʻa a paʻakikī, ke kuhikuhi ʻia e ka dermatologist.
“Moderate-to-severe plaque psoriasis can make it difficult to feel comfortable in your own skin and the search for an effective treatment can be as challenging as the disease itself,”.